ASHLEY ESPINOZA: Open Payments
NPI 1770359051 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,501 in 56 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,684 · 2025 $1,501
Food & beverage: $1,497Travel & lodging: $3
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $206 |
| AstraZeneca Pharmaceuticals LP | 8 | $182 |
| Novo Nordisk Inc | 10 | $181 |
| PFIZER INC. | 7 | $142 |
| ABBVIE INC. | 6 | $141 |
| UCB, Inc. | 1 | $125 |
| Astellas Pharma US Inc | 1 | $122 |
| Corcept Therapeutics | 3 | $71 |
| E.R. Squibb & Sons, L.L.C. | 1 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $51 |
Products named: EBGLYSS, Bimzelx, Veozah, UBRELVY, AIRSUPRA, FARXIGA, Korlym, Ozempic.
Industry payments across NC — which companies pay providers there.
